Optimizing therapy of seizures in patients with HIV and cysticercosis

Neurology

Volumn 67, Issue 12 SUPPL. 4, 2006, Pages

  Bhigjee, A I ^a   Rosemberg, S ^b  

^a INKOSI ALBERT LUTHULI CENTRAL HOSPITAL   (South Africa)

^b Division of Neurology   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTICONVULSIVE AGENT; ANTIPARASITIC AGENT; ANTIRETROVIRUS AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CORTICOSTEROID; DEXAMETHASONE; EFAVIRENZ; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRAZIQUANTEL; PREGABALIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

BRAIN ISCHEMIA; CLINICAL TRIAL; CYSTICERCOSIS; DISEASE SEVERITY; DRUG BINDING; DRUG METABOLISM; ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MENINGITIS; NEUROCYSTICERCOSIS; PRIORITY JOURNAL; RASH; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

EID: 33845720187     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.67.12_suppl_4.s19     Document Type: Review

References (34)

1. UNAIDS 2004. Global summary of the AIDS epidemic. December 2005. Accessed at http://www.unaids.org/epi/2005/doc/report_pdf.asp on 3 April 2006.
2. Berger JR, Moskowitz L, Fischil M, Kelly RE. Neurological disease as a presenting manifestation of acquired immunodeficiency syndrome. South Med J 1987;80:683-686.
3. Holtzmann DM, Kaku DA, So YT. New onset seizures associated with human immunodeficiency virus: causation and clinical features in 100 cases. Am J Med 1989:87:173-177.
4. Wong MC, Suite ND, Laban DR. Seizures in human immunodeficiency virus infection. Arch Neurol 1990;47:640-642.
5. Pascual-Sedano B, Inanzo A, Marti-Fabregas J, et al. Prospective study of new-onset seizures in patients with human immunodeficiency virus infection: etiologic and clinical aspects. Arch Neurol 1999;56:609-612.
6. Chadha DS, Handa A, Sharma SK, Vadarajualu P, Singh AP. Seizures in patients with human immunodeficiency virus. J Assoc Physicians India 2000;48:573-576.
7. Carpio A, Neurocysticercosis: an update. Lancet Infect Dis 2002;2:751-762.
8. DeGiorgio CM, Medina MT, Durón R, Escueta SP. Neurocysticercosis. Epilepsy Curr 2004;4:107-111.
9. DeGiorgio CM, Sorvillo F, Escueta SP. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2005;64:1468. Abstract.
10. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2004;63:1559-1564.
11. Montano SM, Villaran MV, Ylquimiche L, et al. Cysticercosis Working Group in Peru. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 2005;65:229-233.
12. Del Brutto OH, Santibanez R, Idrovo L, et al. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 2005;46:583-587.
13. Nicoletti A, Bartoloni A, Sofia V, et al. Epilepsy and neurocysticercosis in rural Bolivia: a population-based study. Epilepsia 2005;46:1127-1132.
14. Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B, Bouteille B, Nsizabira L, Preux PM. Cysticercosis as a major risk factor for epilepsy in Burundi, east Africa. Epilepsia 2003;44:950-955.
15. Moulignier A, Mikol J, Pialoux G, Fenelon G, Gray F, Thiebaut JB. AIDS- associated progressive multifocal leukoencephalopathy revealed by new onset seizures. Am J Med 1995;99:64-68.
16. Bhigjee AI, Naidoo K, Patel VB, Govender D. Intracranial mass lesions in HIV positive patients - the Kwazulu-Natal experience. S Afr Med J 1999;89:1284-1288.
17. th ed. New York: Raven Press, 1995. 345-350.
18. Jennings HR, Romanelli F. The use of valproic acid in HIV positive patients. Ann Pharmacother 1999;33:1113-1116.
19. Maggi JD, Helman MH. The effect of divalproex sodium on viral load: a retrospective review of HIV positive patients with manic syndromes. Can J Psychiatry 2001;46:359-362.
20. Lehrman G, Hogue B, Palmer S, et al. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 2005;366:549-555.
21. Romanelli F, Ryan M. Seizures in HIV-seropositive individuals. Epidemiology and treatment. CNS Drugs 2002;16:91-98.
22. Locatelli P, Lapadula G, Costarelli S, et al. Long term follow up of levetiracetam in patients with HIV infection and HAART therapy. 26th IEC Proceedings. Epilepsia 2005;46:3-415. Abstract 204.
23. Tseng AL, Foisy M. Significant interactions with new antiretrovirals and psychotropic drugs. Ann Pharmacother 1999;33:461-473.
24. Barry M, Gibbons S. Back D, et al. Protease inhibitors in patients with HIV disease: clinically important pharmacokinetic consideration. Clin Pharmacokinet 1997;32:194-209.
25. Garcia AB, Latorse IA, Porta EJ, et al. Protease inhibitors-induced carbamazepine toxicity. Clin Neuropharmacol 2000;23:216-218.
26. Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004,62:1934-1938.
27. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to analysis of 203 patients. Neurology 1992;42:389-392.
28. Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002;59:1730-1734.
29. Salinas R, Counsell C, Prasad K, Gelband H, Garner P. Treating neurocysticercosis medically: a systematic review of randomized, controlled trials. Trop Med Int Health 1999;4:713-718.
30. Vasquez N, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696-701.
31. Garcia HH, Pretell EJ, Gilman RH, et al. Cysticercosis Working Group in Peru - a trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249-258.
32. Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediatr 2003;143:111-114.
33. Singhi P, Jain V, Khandelwal N. Corticosteroids versus albendazole for the treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. J Child Neurol 2004;19:323-327.
34. Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 2004;62:2236-2240.